Jun 22, 2022 | HYPERKALEMIA
2) This #accredited #tweetorial series on #kidneydisease #hyperkalemia is supported by an independent educational grant from AstraZeneca and is intended for healthcare providers. Accreditation statement & faculty disclosures are at https://t.co/gvXca4G9Xm.—...
Apr 19, 2022 | HYPERKALEMIA
1) Welcome to our #accredited #tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered...
Aug 25, 2021 | HYPERKALEMIA
2) This program is intended for healthcare professionals and is supported by educational grants from AstraZeneca, Bayer, Chiesi, and NovoNordisk. See archived programs, all by expert authors, still available for credit at https://t.co/U6Mo1oSwIh— cardio-met...
Jun 17, 2021 | HYPERKALEMIA
Supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. This program is intended for healthcare providers.— cardio-met (@cardiomet_CE) June 15, 2021 3) Risk Factors for #hyperkalemia include: Advanced stages of #CKD, #heartfailure,...
Mar 25, 2021 | HYPERKALEMIA
2) . . . Supported by educational grant funding from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. Follow this thread for credit. And here is a case . . .— cardio-met (@cardiomet_CE) March 22, 2021 4) P 75, BP 110/60, listless. Mucous membranes dry, appears...
Feb 12, 2021 | HYPERKALEMIA
This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter “real time” you can review the course material here and earn the same credit. 2) . . . Supported by Abbott, AstraZeneca,...